Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Implementing TMB measurement in clinical practice: considerations on assay requirements.

Büttner R, Longshore JW, López-Ríos F, Merkelbach-Bruse S, Normanno N, Rouleau E, Penault-Llorca F.

ESMO Open. 2019 Jan 24;4(1):e000442. doi: 10.1136/esmoopen-2018-000442. eCollection 2019.

2.

Multiplex testing for Factor II and Factor V mutations in thrombophilia: technical verification and clinical validation of the cobas® Factor II and Factor V test.

Longshore JW, DeMartin K, Yu K, Das P, Zhang G, Rehage TT, Jethwaney D, Karwowska S.

J Thromb Thrombolysis. 2019 Jan;47(1):87-95. doi: 10.1007/s11239-018-1745-8.

3.

Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non-Small-Cell Lung Cancer.

Büttner R, Gosney JR, Skov BG, Adam J, Motoi N, Bloom KJ, Dietel M, Longshore JW, López-Ríos F, Penault-Llorca F, Viale G, Wotherspoon AC, Kerr KM, Tsao MS.

J Clin Oncol. 2017 Dec 1;35(34):3867-3876. doi: 10.1200/JCO.2017.74.7642. Epub 2017 Oct 20. Review.

PMID:
29053400
4.

The evolution of routine PCR testing: insights from the core lab model.

Longshore JW.

MLO Med Lab Obs. 2015 Nov;47(11):22-3. No abstract available.

PMID:
26685422
5.

Molecular Testing for Treatment of Metastatic Non-Small Cell Lung Cancer: How to Implement Evidence-Based Recommendations.

Levy BP, Chioda MD, Herndon D, Longshore JW, Mohamed M, Ou SH, Reynolds C, Singh J, Wistuba II, Bunn PA Jr, Hirsch FR.

Oncologist. 2015 Oct;20(10):1175-81. doi: 10.1634/theoncologist.2015-0114. Epub 2015 Sep 1.

6.

BRAF p.V600E immunohistochemistry in challenging samples: about false-positive and false-negative results--reply.

Fisher KE, Cohen C, Palma JF, Longshore JW.

Hum Pathol. 2015 Jul;46(7):1065-6. doi: 10.1016/j.humpath.2015.03.011. Epub 2015 Apr 11. No abstract available.

PMID:
25971545
7.

Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays.

Fisher KE, Cohen C, Siddiqui MT, Palma JF, Lipford EH 3rd, Longshore JW.

Hum Pathol. 2014 Nov;45(11):2281-93. doi: 10.1016/j.humpath.2014.07.014. Epub 2014 Aug 7.

PMID:
25228337
8.

A retrospective analysis of the clinical performance of human papillomavirus testing using SurePath sample collection.

McDermott JE, Symanowski JT, Livasy CA, Greger G, Longshore JW.

J Am Soc Cytopathol. 2014 May - Jun;3(3):165-169. doi: 10.1016/j.jasc.2014.02.002. Epub 2014 Feb 23.

PMID:
31051741
9.

Molecular diversity of diazotrophs in oligotrophic tropical seagrass bed communities.

Bagwell CE, Rocque JR, Smith GW, Polson SW, Friez MJ, Longshore JW, Lovell CR.

FEMS Microbiol Ecol. 2002 Feb 1;39(2):113-9. doi: 10.1111/j.1574-6941.2002.tb00912.x.

10.
11.

American College of Medical Genetics statement of diagnostic testing for uniparental disomy.

Shaffer LG, Agan N, Goldberg JD, Ledbetter DH, Longshore JW, Cassidy SB.

Genet Med. 2001 May-Jun;3(3):206-11. No abstract available.

12.

The HOPA gene dodecamer duplication is not a significant etiological factor in autism.

Michaelis RC, Copeland-Yates SA, Sossey-Alaoui K, Skinner C, Friez MJ, Longshore JW, Simensen RJ, Schroer RJ, Stevenson RE.

J Autism Dev Disord. 2000 Aug;30(4):355-8.

PMID:
11039861
13.

Evidence that a dodecamer duplication in the gene HOPA in Xq13 is not associated with mental retardation.

Friez MJ, Essop FB, Krause A, Castiglia L, Ragusa A, Sossey-Alaoui K, Nelson RL, May MM, Michaelis RC, Srivastava AK, Schwartz CE, Stevenson RE, Goldman A, Villard L, Longshore JW.

Hum Genet. 2000 Jan;106(1):36-9.

PMID:
10982179
14.

Instability of the FMR2 trinucleotide repeat region associated with expanded FMR1 alleles.

Brown TC, Tarleton JC, Go RC, Longshore JW, Descartes M.

Am J Med Genet. 1997 Dec 31;73(4):447-55.

PMID:
9415473
15.

Terminal deletion of the long arm of chromosome 4 in a mother and two sons.

Descartes M, Keppler-Noreuil K, Knops J, Longshore JW, Finley WH, Carroll AJ.

Clin Genet. 1996 Dec;50(6):538-40. Review.

PMID:
9147894
17.

Over-representation of the disease associated (CAG) and (CGG) repeats in the human genome.

Han J, Hsu C, Zhu Z, Longshore JW, Finley WH.

Nucleic Acids Res. 1994 May 11;22(9):1735-40.

Supplemental Content

Loading ...
Support Center